These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6088932)

  • 1. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
    Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
    Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative.
    Waksman G; Bouboutou R; Chaillet P; Devin J; Coulaud A; Hamel E; Besselievre R; Costentin J; Fournie-Zaluski MC; Roques BP
    Neuropeptides; 1985 Feb; 5(4-6):529-32. PubMed ID: 3839056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
    Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
    Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties.
    Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP
    J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.
    Chérot P; Devin J; Fournié-Zaluski MC; Roques BP
    Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
    Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes.
    Hernandez JF; Soleilhac JM; Roques BP; Fournié-Zaluski MC
    J Med Chem; 1988 Sep; 31(9):1825-31. PubMed ID: 2900898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
    Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H
    Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recognition of "enkephalinase" and angiotensin-converting enzyme by new carboxyalkyl inhibitors.
    Fournié-Zaluski MC; Soroca-Lucas E; Waksman G; Llorens C; Schwartz JC; Roques BP
    Life Sci; 1982 Dec; 31(26):2947-54. PubMed ID: 6298535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of the analgesic neuropeptides kyotorphin and neo-kyotorphin on enkephalin-degrading enzymes from monkey brain.
    Hazato T; Kase R; Ueda H; Takagi H; Katayama T
    Biochem Int; 1986 Mar; 12(3):379-83. PubMed ID: 3011001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of enkephalin-degradating enzymes from calf-brain striatum.
    van Amsterdam JG; van Buuren KJ; Soudijn W
    Biochem Biophys Res Commun; 1983 Sep; 115(2):632-41. PubMed ID: 6578795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin III: a potent inhibitor of enkephalin-degrading enzymes and an analgesic agent.
    Shimamura M; Kawamuki K; Hazato T
    J Neurochem; 1987 Aug; 49(2):536-40. PubMed ID: 3037031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
    Altstein M; Bachar E; Vogel Z; Blumberg S
    Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isolation of a peptidyl dipeptidase from mouse brain cytosol that cleaves adrenocorticotropic hormone-(7-10) and des-tyrosine-enkephalins.
    Neidle A; Kelly JA
    Arch Biochem Biophys; 1984 Aug; 233(1):115-26. PubMed ID: 6087738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.
    Elliott RL; Marks N; Berg MJ; Portoghese PS
    J Med Chem; 1985 Sep; 28(9):1208-16. PubMed ID: 2993614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of enkephalin degrading enzymes by metal chelating reagents.
    Altstein M; Blumberg S; Vogel Z
    Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enkephalin-degrading enzyme inhibitors. Crucial role of the C-terminal residue on the inhibitory potencies of retro-hydroxamate dipeptides.
    Fournié-Zaluski MC; Hernandez JF; Soleilhac JM; Renwart N; Peyroux J; Xie J; Roques BP
    Int J Pept Protein Res; 1989 Feb; 33(2):146-53. PubMed ID: 2707969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.